BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33937050)

  • 1. Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis.
    Chen Y; Jin L; Jiang Z; Liu S; Feng W
    Front Oncol; 2021; 11():644426. PubMed ID: 33937050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and Validation of Significant Genes with Poor Prognosis in Pathologic Stage-I Lung Adenocarcinoma.
    Deng Y; Chen X; Huang C; Song J; Feng S; Chen X; Zhou R
    J Oncol; 2022; 2022():3794021. PubMed ID: 35444699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated analysis of prognostic and immune infiltrates for hub genes as potential survival indicators in patients with lung adenocarcinoma.
    Xu Z; Wang S; Ren Z; Gao X; Xu L; Zhang S; Ren B
    World J Surg Oncol; 2022 Mar; 20(1):99. PubMed ID: 35354488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of potential biomarkers and their predictive value in early stage non-small cell lung cancer: a bioinformatics analysis.
    Tu H; Wu M; Huang W; Wang L
    Transl Lung Cancer Res; 2019 Dec; 8(6):797-807. PubMed ID: 32010558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of crucial genes associated with lung adenocarcinoma by bioinformatic analysis.
    Dai JJ; Zhou WB; Wang B
    Medicine (Baltimore); 2020 Oct; 99(44):e23052. PubMed ID: 33126397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated bioinformatics analysis of microarray data from the GEO database to identify the candidate genes linked to poor prognosis in lung adenocarcinoma.
    Liu X; Li L; Xie X; Zhuang D; Hu C
    Technol Health Care; 2023; 31(2):579-592. PubMed ID: 36336945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Expression of
    Deng H; Huang Y; Wang L; Chen M
    Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potential key molecular biomarkers in lung adenocarcinoma by bioinformatics analysis.
    Guo P; Xu T; Jiang Y; Shen W
    Transl Cancer Res; 2022 Jan; 11(1):227-241. PubMed ID: 35261899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
    Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a transcription factor‑cyclin family genes network in lung adenocarcinoma through bioinformatics analysis and validation through RT‑qPCR.
    Yang X; Zhou Y; Ge H; Tian Z; Li P; Zhao X
    Exp Ther Med; 2023 Jan; 25(1):63. PubMed ID: 36605530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
    Yu Y; Tian X
    Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
    Ni KW; Sun GZ
    Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics analysis of microarray data to identify the candidate biomarkers of lung adenocarcinoma.
    Guo T; Ma H; Zhou Y
    PeerJ; 2019; 7():e7313. PubMed ID: 31333911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRT8 and KRT19, associated with EMT, are hypomethylated and overexpressed in lung adenocarcinoma and link to unfavorable prognosis.
    Wang W; He J; Lu H; Kong Q; Lin S
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32519739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of hub genes and exploration of multi-omics level alterations in the landscape of lung adenocarcinoma.
    Li G; Atiq W; Hashmi MF; Ibrahim SS; Al Abdulsalam KA; Kadham MJ; Al-Azzawi AKJ; Aufy M; Abdel-Maksoud MA
    Am J Transl Res; 2023; 15(3):1550-1568. PubMed ID: 37056815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of key candidate genes associated with prognosis of lung adenocarcinoma by integrated bioinformatical analysis.
    Li J; Li Y; Jin M; Huang L; Wang X
    Transl Cancer Res; 2020 Nov; 9(11):6841-6856. PubMed ID: 35117293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of hub genes associated with prognosis in non-small cell lung cancer by integrated bioinformatics analysis.
    Zeng Y; Li N; Chen R; Liu W; Chen T; Zhu J; Zeng M; Cheng J; Huang J
    Transl Cancer Res; 2020 Nov; 9(11):7149-7164. PubMed ID: 35117319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.